Sat.Jul 16, 2022 - Fri.Jul 22, 2022

article thumbnail

The fairytale of DTC TV ads

World of DTC Marketing

The pandemic is changing consumer behavior, and there is zero chance they will return to their carefree spending ways. Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. According to a 2019 study from Kantar , a whopping 70 percent of consumers say they see the same ads over and over again.

article thumbnail

Episode 93 – Corporate Accounts…What Has Changed with Frank Ripullo II, Managing Partner, Excelerant Consulting

Medical Device Success

Reading time: 2 – 3 minutes. Great insights and advice on Corporate Accounts in MedTech. Multiple factors have impacted the relationships between MedTech companies and their customers over the past 2 years. The pandemic started a cascade of events influencing elective surgeries, budgets, HCP shortages, HCP costs, supply chains and so on. One area these factors have come together to create change is in the management of corporate accounts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Reimagining healthcare in a quantum era

MedCity News

With promises of more efficient and reliable diagnoses, future breakthroughs in personalized medicine and targeted therapeutics, and an expedited R&D lifecycle, industry leaders must be prepared to invest in quantum technologies to deliver better outcomes for their organizations and patients.

article thumbnail

Connecting your Digital Health Strategy from Clinical to Commercial

PharmExec

Thursday, July 21st 2022 at 11am EST, 8am PST, 5pm CEST Join this webinar to hear industry thought leaders discuss how data and experiences serve clinical and commercial needs, explore which platforms and technologies can enable a robust digital health ecosystem, and share recommendations for building a digital health strategy fit for your business.

139
139
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Are new weight loss drugs an answer or problem?

World of DTC Marketing

Worldwide obesity rates have tripled since 1975, with 650 million adults obese in 2016, according to the World Health Organization. In 2019, the OECD declared that developed countries’ plans to tackle the problem largely failed. And the Covid-19 pandemic only underscored that obesity puts people at greater risk for infectious disease but are new weight loss drugs the answer?

article thumbnail

Brain-Computer Interfaces at Home: Interview with Dr. Solzbacher of Blackrock Neurotech

Medgadget

Blackrock Neurotech , a medtech company based in Salt Lake City, has pioneered an array of brain-computer interface technologies. Medgadget last spoke with Blackrock Neurotech a year ago about their thought-to-text brain computer interface, but since the company signed an agreement with a research institution to develop portable brain computer interface (BCI) systems.

Medical 127

More Trending

article thumbnail

Twill taps YourCoach for DtX-health coaching integration

pharmaphorum

Health coaching ecosystem YourCoach Health and digital therapeutics company Twill (formerly Happify Health ) are teaming up to offer access to YourCoach’s cross-specialty health coaches via Twill’s Duet platform, the companies announced today. “Digital therapy has been around for a really long time,” YourCoach Cofounder and CEO Marina Borukhovich told pharmaphorum.

article thumbnail

Healthcare doesn’t give a damn about patients

World of DTC Marketing

A new analysis released Wednesday by Patients for Affordable Drugs estimates that pharmaceutical companies in the U.S. have raised drug prices 1,186 times so far this year. But they’re not alone. Health insurers in individual marketplaces across 13 states and Washington D.C. will raise rates an average of 10% next year, according to a review of rate filings by the Kaiser Family Foundation.

article thumbnail

US FDA grants approval to Incyte’s Opzelura cream for vitiligo treatment

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Incyte’s Opzelura (ruxolitinib) cream 1.5% as a topical treatment of nonsegmental vitiligo in adults and paediatric patients aged 12 years and above. Opzelura is a topical formulation of a Janus kinase (JAK) inhibitor. With the latest development, Opzelura has became the first treatment for repigmentation in patients with vitiligo to receive FDA approval.

article thumbnail

Elevating patient care from the home

MedCity News

By adding adherence and connectivity capabilities to home-based solutions, clinicians can maintain open lines of communication with patients, helping patients better care for themselves from the comfort of their homes.

Patients 140
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Roche CEO Severin Schwan to stand down after 14 years

pharmaphorum

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group. Schwan (pictured above) has been nominated as chair of Roche’s board of directors however, to succeed Christoph Franz will not seek re-election after more than eight years in the role, so will still be intimately involved in the company’s affairs.

Sales 117
article thumbnail

Research integrity: five tips for authors, editors and reviewers

Clarivate

The Web of Science is taking steps to help the research community better understand research integrity. In this blog post, we discuss our free courses in the Web of Science Academy, new features including ‘retraction alerts’ and share some practical tips for researchers to help uphold research integrity in their everyday work and research community.

Ethics 105
article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

A key factor of Pfizer’s Covid-19 antiviral Paxlovid efficacy has been early intervention, but getting it in time has proven to be a challenge. On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

article thumbnail

The medtech industry’s responsibility in addressing the socioeconomic barriers to accessing and succeeding on renal replacement therapy

MedCity News

Aside from rallying for more patient-oriented reimbursement and removing the red tape involved so that providers can provide home-based dialysis care, medical device manufacturers must also offer a turnkey solution for home-based therapy that includes servicing the device in a door-to-door model.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

UK scientists say they have found cancer driver in junk DNA

pharmaphorum

It has suspected for many years that some diseases may be linked to non-coding or ‘junk’ DNA, but the mechanism behind the pathology hasn’t been worked out. Now, scientists in the UK think they have found a culprit implicated in cancer. Junk DNA is a term used to describe the 97% of the genetic sequence in human cells found between the 3% coding for our 20,000 genes, once thought to be inert.

Leads 113
article thumbnail

Smart Textiles Recognize Body Movements

Medgadget

Engineers at MIT have developed smart textiles that can detect and recognize body movements. The garments fit snugly, and contain a network of pressure sensors that can detect movement, and in conjunction with machine learning approaches, the technology can learn to recognize specific movements in wearers. The fabric contains conductive yarns and piezoresistive components that change their resistance when pressure is applied.

article thumbnail

Gladstone and UCSF scientists discover BET protein role in Covid-19

Pharmaceutical Technology

Researchers at Gladstone Institutes and UC San Francisco (UCSF) have discovered in a study that bromodomain and extraterminal (BET) proteins are vital for the body to fight Covid-19 infection. . The research also found that BET proteins play two distinct roles in affecting how the SARS-CoV-2 virus interacts with human cells. . They provide the virus with a pathway into cells while aiding cells to defend themselves.

Leads 111
article thumbnail

5 steps to defining your healthcare mobile app business goals

MedCity News

There’s a lot of open water between recognizing the potential for an app and launching one that actually makes people’s lives better. The key to getting it right is defining how the app will impact business-level goals. Here are five steps to defining business goals for a mobile healthcare app.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe

pharmaphorum

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. The CMA delivered a preliminary judgment in the case last year which concluded that Pfizer and Flynn abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to balloon from around £2 million a year in 2012 to £50 million the following year.

article thumbnail

Artificial Muscles are Stronger and More Flexible than Real Muscle

Medgadget

Engineers at the University of California Los Angeles created artificial muscles that are stronger and more flexible than the real thing. The new material is an example of a dielectric elastomer, which is an electroactive polymer that can change its shape or size when stimulated using electricity. The researchers tweaked the crosslinking between polymer chains within the material, allowing it to be more flexible while maintaining its strength.

article thumbnail

AstraZeneca to deliver Covid-19 antibody therapy doses to Switzerland

Pharmaceutical Technology

AstraZeneca has signed a deal with the Federal Office of Public Health (FOPH) of Switzerland to deliver over 1,200 doses of antibody therapy, tixagevimab and cilgavimab combination (AZD7442), for Covid-19 prevention and treatment. Tixagevimab and cilgavimab are two long-acting antibodies (LAABs) obtained from the B-cells of patients convalescing following Covid-19.

article thumbnail

How technology is meeting the changing needs of the home health care worker

MedCity News

Serving more patients at home makes efficiency a greater priority for home health care workers and rugged mobile technology is a key differentiator, empowering them to digitize manual workflows.

Patients 134
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

GSK consumer health spin-off Haleon starts trading

pharmaphorum

GSK’s consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion). The new company – which has achieved the largest London listing in a decade – has annual sales of around £10 billion from brands like Sensodyne toothpaste, Voltaren and Panadol painkillers, and Centrum multivitamins, making it the second-largest consumer health company in the world.

Biopharma 122
article thumbnail

8 Ultimate Ways To Market Your Virtual Assistant Business

Medico Reach

If you own a virtual assistant business, then you are one of the only businesses that did well in the pandemic. Thanks to the onset of the COVID-19 virus, the adoption of remote work and virtual assistants saw a significant uptick. A certain study also states that hiring virtual assistants can help you save up to 78% of the operating cost value. On an average, this amounts to a U.S. employer saving around USD 11,000 in hiring costs by opting for a remote workforce.

article thumbnail

ASRS conference reveals hopeful outcomes for gene therapy RGX-314 in retinal diseases

Pharmaceutical Technology

Pipeline therapies within the diabetic macular oedema (DME) space have recently gathered interest following the American Society of Retina Specialists (ASRS) Annual Meeting, which took place on 13–16 July. The spotlight was placed on many up-and-coming pharmacotherapies for retinal diseases, one of which was AbbVie’s/Regenxbio’s gene therapy RGX-314.

Patients 104
article thumbnail

Geisinger Health Plan addresses burdensome prior auth process with Cohere Health’s platform

MedCity News

Geisinger Health Plan is licensing Cohere Health’s AI-driven utilization management technology and services platform, designed to support value-based care delivery and streamline the prior authorization process.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Amazon ratchets up its health ambitions, buying US primary care group

pharmaphorum

Amazon has accelerated its expansion into the healthcare sector with an all-cash deal to acquire One Medical, a US group that provides virtual and in-person primary care services using a subscription fee model. Amazon is buying One Medical for $18 per share, valuing the company at around $3.9 billion and making it one of the online retail giant’s largest-ever acquisitions – and by far its biggest within the health category.

Medical 104
article thumbnail

Largest-Ever Industry Report Reveals Video Meetings 3x More Effective and Companies Using Them Most Gain Advantage

PharmExec

Data from over 130 million quarterly HCP-field interactions across 80% of global biotech and pharma companies unveiled in Veeva Pulse Field Trends Report - industrywide data shows frequent use of key digital channels is vital for effective HCP engagement.

Pharma 98
article thumbnail

Limited Time Summer Project Event for Advocacy and Non-profits!

Storyvine

Working on a limited budget but looking for big ROI? Our “6 for 6” summer initiative is your chance to save big on unlimited videos. Grab donors’ attention and spread awareness for your cause with real people telling real stories. For the next 6 months, we’re offering our Storyvine Quick Project starting at $6,000. Get started quickly with our easy-to-use semi-custom template designed for advocacy groups and non-profits.

article thumbnail

DOJ charges dozens for $1.2B in telemedicine fraud scheme

MedCity News

The charges involve some of the first cases in the country involving fraudulent cardiovascular genetic testing, a “burgeoning scheme,” according to a news release from the DOJ.

Biopharma 120
article thumbnail

ABM Evolution: How Top Marketers Are Using Account-Based Strategies

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.